Co-Partners
Associate Partners
Get App

Co-Partners

Associate Partners

Close Ad
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Profit & Loss account - Cadila Healthcare

Cadila Healthcare

BSE: 532321|NSE: CADILAHC|ISIN: INE010B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 20, 10:32
251.65
2.1 (0.84%)
VOLUME 212,268
LIVE
NSE
May 20, 10:32
251.90
2.25 (0.9%)
VOLUME 1,370,138
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Profit & Loss account of Cadila Healthcare

------------------- in Rs. Cr. -------------------
Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
12 mths 12 mths 12 mths 12 mths 12 mths
INCOME
Revenue From Operations [Gross] 5,588.70 3,098.00 6,529.60 4,763.60 3,587.30
Less: Excise/Sevice Tax/Other Levies 12.70 43.80 96.40 77.50 62.80
Revenue From Operations [Net] 5,576.00 3,054.20 6,433.20 4,686.10 3,524.50
Other Operating Revenues 233.90 176.50 598.80 598.30 517.60
Total Operating Revenues 5,809.90 3,230.70 7,032.00 5,284.40 4,042.10
Other Income 207.90 583.10 174.90 185.20 308.60
Total Revenue 6,017.80 3,813.80 7,206.90 5,469.60 4,350.70
EXPENSES
Cost Of Materials Consumed 1,564.00 926.70 1,379.40 1,286.10 1,068.10
Purchase Of Stock-In Trade 318.60 228.80 462.20 441.50 382.70
Changes In Inventories Of FG,WIP And Stock-In Trade -186.90 -147.00 50.20 -76.00 -35.70
Employee Benefit Expenses 826.00 650.80 695.80 607.10 525.10
Finance Costs 63.90 11.10 26.50 42.80 42.50
Depreciation And Amortisation Expenses 293.10 250.90 221.20 211.90 127.40
Other Expenses 1,641.90 1,250.30 1,867.80 1,491.60 1,294.90
Total Expenses 4,520.60 3,171.60 4,703.10 4,005.00 3,405.00
Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
12 mths 12 mths 12 mths 12 mths 12 mths
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 1,497.20 642.20 2,503.80 1,464.60 945.70
Profit/Loss Before Tax 1,497.20 642.20 2,503.80 1,464.60 945.70
Tax Expenses-Continued Operations
Current Tax 318.30 59.40 432.30 196.30 62.80
Deferred Tax 88.10 -79.10 34.00 0.00 0.00
Tax For Earlier Years 0.00 0.00 0.00 -2.80 -20.70
Total Tax Expenses 406.40 -19.70 466.30 193.50 42.10
Profit/Loss After Tax And Before ExtraOrdinary Items 1,090.80 661.90 2,037.50 1,271.10 903.60
Profit/Loss From Continuing Operations 1,090.80 661.90 2,037.50 1,271.10 903.60
Profit/Loss For The Period 1,090.80 661.90 2,037.50 1,271.10 903.60
Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
12 mths 12 mths 12 mths 12 mths 12 mths
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.) 10.66 6.47 19.90 62.08 44.13
Diluted EPS (Rs.) 10.66 6.47 19.90 62.08 44.13
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS
Imported Raw Materials 0.00 0.00 0.00 334.00 240.30
Indigenous Raw Materials 0.00 0.00 0.00 334.00 602.40
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares 0.00 0.00 0.00 42.80 35.50
Indigenous Stores And Spares 0.00 0.00 0.00 48.50 53.20
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 0.00 327.60 573.30 245.70 184.30
Tax On Dividend 0.00 1.90 105.80 45.00 27.30
Equity Dividend Rate (%) 350.00 320.00 320.00 240.00 180.00
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for cadilahealthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.